Interview: Dr. Michael Oellerich (Germany)

Interview about biomarkers to achieve personalized immunosuppression in transplant recipients.

0
1853

Michael Oellerich, MD, HonMD, FACB, FAMM, FFPath (RCPI),FRCPath, is a chemical pathologist and a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August University, Göttingen, Germany. From 1996 to 1998, he served as Dean of the Faculty of Medicine.

He was President of WASPaLM, IATDMCT, DGLM, and DGKL. He is Editor-in-Chief of Therapeutic Drug Monitoring and was Associate Editor of Clinical Chemistry. His research interests include biomarkers in transplantation, proteomics, LC-MS/MS, and molecular diagnostics. He authored more than 400 publications. He received various awards (e.g. IATDMCT Charles Pippenger Award, WASPaLM Gold-Headed Cane).

Interview about biomarkers to achieve personalized immunosuppression in transplant recipients.